2025. Pancreatic cancer in Algeria – Cost-effectiveness study: A Comparative Study of FOLFIRINOX and GEMCITABINE Protocols. CIMEGS–SEJ (Socio-Economic Journal). 1, 2 (Oct. 2025), 88–97.